Thursday, May 28, 2015
Public Release: 28-May-2015 ASCO: MEDI4736 combined with tremelimumab results in acceptable toxicity in NSCLC patients H. Lee Moffitt Cancer Center & Research Institute Advanced non-small cell lung cancer patients have few effective treatment options…
… , Fla. - Advanced non-small cell lung cancer (NSCLC) patients have few effective …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment